UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A risk prediction model for hepatocellular carcinoma after hepatitis B surface antigen seroclearance: Has the correct patient cohort been targeted?

Journal of hepatology, 2023-10, Vol.79 (4), p.e154-e155

2023

Volltextzugriff (PDF)

Not Just Another “Bloody” Case of Right Heart Failure

Gastroenterology (New York, N.Y. 1943), 2023-09, Vol.165 (3), p.538-540

2023

Volltextzugriff (PDF)

Gastric adenocarcinoma causing biliary obstruction without ductal dilatation: a case report

Journal of medical case reports, 2019-03, Vol.13 (1), p.72-72, Article 72

2019

Volltextzugriff (PDF)

Letter to the Editor: Predicting mortality after transjugular intrahepatic portosystemic shunt in older adult patients with cirrhosis-Does novelty supplant the standard?

Hepatology (Baltimore, Md.), 2023-04, Vol.77 (4), p.E74-n/a

2023

Volltextzugriff (PDF)

Long-Term Continuous Terlipressin Infusion Improves Cardiac Reserve in Patients With Decompensated Cirrhosis

Clinical gastroenterology and hepatology, 2024-08

2024

Volltextzugriff (PDF)

Artificial Intelligence in Hepatology: A Narrative Review

Seminars in liver disease, 2021-11, Vol.41 (4), p.551-556

2021

Volltextzugriff (PDF)

THU-450 - Prevalence of dysmetabolic iron overload syndrome in non-alcoholic fatty liver disease

Journal of hepatology, 2023-06, Vol.78, p.S625-S626

2023

Volltextzugriff (PDF)

Prevalence of dysmetabolic iron overload syndrome in non-alcoholic fatty liver disease

Journal of hepatology, 2023-06, Vol.78, p.S625-S626

2023

Volltextzugriff (PDF)

An Unusual Cause of Lower Gastrointestinal Bleeding

Gastroenterology (New York, N.Y. 1943), 2020-03, Vol.158 (4), p.834-835

2020

Volltextzugriff (PDF)

Determinants of Short- and Long-Term Outcomes of an Australian Cohort of Patients Admitted with Alcoholic Hepatitis

Digestive diseases and sciences, 2022-07, Vol.67 (7), p.3356-3365

2022

Volltextzugriff (PDF)

SAT-123 - Non-alcoholic fatty liver disease prevalence has increased in Australia, particularly amongst women

Journal of hepatology, 2023-06, Vol.78, p.S861-S862

2023

Volltextzugriff (PDF)

Non-alcoholic fatty liver disease prevalence has increased in Australia, particularly amongst women

Journal of hepatology, 2023-06, Vol.78, p.S861-S862

2023

Volltextzugriff (PDF)

Letter: the diagnostic and prognostic significance of liver histology in alcoholic hepatitis

Alimentary pharmacology & therapeutics, 2021-09, Vol.54 (6), p.862-863

2021

Volltextzugriff (PDF)

COVID-19 pandemic impact on alcoholic hepatitis healthcare utilisation

Journal of hepatology, 2022-07, Vol.77, p.S134-S134

2022

Volltextzugriff (PDF)

Assessing the safety profile of voriconazole use in suspected COVID-19-associated pulmonary aspergillosis–a two-centre observational study

Medical mycology (Oxford), 2023-06, Vol.61 (6)

2023

Volltextzugriff (PDF)

Steatotic liver disease in rural and regional Victoria, according to the NAFLD and newer diagnostic criteria: retrospective cohort analyses of 2001–03 and 2016–18 data

Medical journal of Australia, 2024-02, Vol.220 (2), p.97-99

2024

Volltextzugriff (PDF)

Testosterone is lower in men with non-alcoholic fatty liver disease and alcohol-related cirrhosis and is associated with adverse clinical outcomes

Scandinavian journal of gastroenterology, 2023-11, Vol.ahead-of-print (ahead-of-print), p.1-7

2023

Volltextzugriff (PDF)

Current understanding and future perspectives on the impact of changing NAFLD to MAFLD on global epidemiology and clinical outcomes

Hepatology international, 2023-10, Vol.17 (5), p.1082-1097

2023

Volltextzugriff (PDF)

A report on the Australian Drug Induced Liver Injury Network: AusDILIN

Journal of hepatology, 2022-07, Vol.77, p.S389-S390

2022

Volltextzugriff (PDF)

EP1190: COVID-19 PANDEMIC IMPACT ON ALCOHOLIC HEPATITIS HEALTHCARE UTILISATION

Gastroenterology (New York, N.Y. 1943), 2022-05, Vol.162 (7), p.S-1278

2022

Volltextzugriff (PDF)

Rate of early hospital readmission amongst cirrhotic patients is high in Australia: experience from a single liver transplant centre

Internal medicine journal, 2022-12, Vol.52 (12), p.2086-2095

2022

Volltextzugriff (PDF)

Non-alcoholic fatty liver disease prevalence in Australia has risen over 15 years in conjunction with increased prevalence of obesity and reduction in healthy lifestyle

Journal of gastroenterology and hepatology, 2023-10, Vol.38 (10), p.1823-1831

2023

Volltextzugriff (PDF)

Drug‐induced liver injury from selective androgen receptor modulators, anabolic‐androgenic steroids and bodybuilding supplements in Australia

Alimentary pharmacology & therapeutics, 2024-04, Vol.59 (8), p.953-961

2024

Volltextzugriff (PDF)

Inflammatory bowel disease incidence, prevalence and 12‐month initial disease course in Tasmania, Australia

Internal medicine journal, 2019-05, Vol.49 (5), p.622-630

2019

Volltextzugriff (PDF)

NAFLD and MAFLD independently increase the risk of major adverse cardiovascular events (MACE): a 20-year longitudinal follow-up study from regional Australia

Hepatology international, 2024-08, Vol.18 (4), p.1135-1143

2024

Volltextzugriff (PDF)

1 – 25 von 67

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(60)
Mit Volltextzugriff
(59)

Publikationsform

Sprache

Englisch
(66)
Portugiesisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

A risk prediction model for hepatocellular carcinoma after hepatitis B surface antigen seroclearance: Has the correct patient cohort been targeted?

Not Just Another “Bloody” Case of Right Heart Failure

Gastric adenocarcinoma causing biliary obstruction without ductal dilatation: a case report

Letter to the Editor: Predicting mortality after transjugular intrahepatic portosystemic shunt in older adult patients with cirrhosis-Does novelty supplant the standard?

Long-Term Continuous Terlipressin Infusion Improves Cardiac Reserve in Patients With Decompensated Cirrhosis

Artificial Intelligence in Hepatology: A Narrative Review

THU-450 - Prevalence of dysmetabolic iron overload syndrome in non-alcoholic fatty liver disease

Prevalence of dysmetabolic iron overload syndrome in non-alcoholic fatty liver disease

An Unusual Cause of Lower Gastrointestinal Bleeding

Determinants of Short- and Long-Term Outcomes of an Australian Cohort of Patients Admitted with Alcoholic Hepatitis

SAT-123 - Non-alcoholic fatty liver disease prevalence has increased in Australia, particularly amongst women

Non-alcoholic fatty liver disease prevalence has increased in Australia, particularly amongst women

Letter: the diagnostic and prognostic significance of liver histology in alcoholic hepatitis

COVID-19 pandemic impact on alcoholic hepatitis healthcare utilisation

Assessing the safety profile of voriconazole use in suspected COVID-19-associated pulmonary aspergillosis–a two-centre observational study

Steatotic liver disease in rural and regional Victoria, according to the NAFLD and newer diagnostic criteria: retrospective cohort analyses of 2001–03 and 2016–18 data

Testosterone is lower in men with non-alcoholic fatty liver disease and alcohol-related cirrhosis and is associated with adverse clinical outcomes

Current understanding and future perspectives on the impact of changing NAFLD to MAFLD on global epidemiology and clinical outcomes

A report on the Australian Drug Induced Liver Injury Network: AusDILIN

EP1190: COVID-19 PANDEMIC IMPACT ON ALCOHOLIC HEPATITIS HEALTHCARE UTILISATION

Rate of early hospital readmission amongst cirrhotic patients is high in Australia: experience from a single liver transplant centre

Non-alcoholic fatty liver disease prevalence in Australia has risen over 15 years in conjunction with increased prevalence of obesity and reduction in healthy lifestyle

Drug‐induced liver injury from selective androgen receptor modulators, anabolic‐androgenic steroids and bodybuilding supplements in Australia

Inflammatory bowel disease incidence, prevalence and 12‐month initial disease course in Tasmania, Australia

NAFLD and MAFLD independently increase the risk of major adverse cardiovascular events (MACE): a 20-year longitudinal follow-up study from regional Australia

Suchergebnisse filtern